Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ixabepilone in Refractory Solid Tumors in Children and Young Adults
NCT00331643Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ixabepilone in rhabdomyosarcoma (RMS), osteosarcoma (OS), Ewing sarcoma, Peripheral Primitive Neuroectodermal Tumor (pPNET), synovial sarcoma (SS), sponsored by National Cancer Institute. Started Apr 2006; status: completed.
02
Drugs
ixabepilone
03
Conditions
rhabdomyosarcoma (RMS)osteosarcoma (OS)Ewing sarcomaPeripheral Primitive Neuroectodermal Tumor (pPNET)synovial sarcoma (SS)
Beyond the preview
Go deeper on NCT00331643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00331643.